Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Alpha-adrenergic receptors are a class of G protein-coupled receptors that mediate the effects of catecholamines (primarily norepinephrine and epinephrine) in the sympathetic nervous system. There are two major types with multiple subtypes: Alpha-1 (α1A, α1B, α1D) receptors are primarily responsible for smooth muscle contraction and vasoconstriction, while Alpha-2 (α2A, α2B, α2C) receptors are involved in feedback inhibition of neurotransmitter release and can influence vascular tone and central nervous system functions. These receptors are prominent targets for drugs treating hypertension, urinary retention, psychiatric disease, and more, with distinct pharmacological profiles depending on subtype selectivity.
Agonists stimulate the receptors to induce downstream signaling (α1: Gq-phospholipase C/calcium mobilization; α2: Gi-inhibition of adenylyl cyclase, lowers cAMP). Antagonists block receptor activity, leading to vasodilation (α1 blockers) or increased neurotransmitter release (α2 blockers).
12 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Alpha-adrenergic receptor alpha-1 and alpha-2 subtypes (α1A, α1B, α1D, α2A, α2B, α2C).